Not Available. The Sixth Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure. Arch Intern Med.1997;157:2413-2446.
Not Available. United States Renal Data System: USRDS 1998 Annual Data Report . Bethesda, Md: US Dept of Health and Human Services; 1999.
Not Available. An Overview of Regular Dialysis Treatment in Japan [as
of December 31, 1998]. Tokyo: Japanese Society for Dialysis Therapy: 1999.
Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men: 16-year
MRFIT findings. JAMA.1997;277:1293-1298.
Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Does racial variation in risk factors explain black-white differences
in the incidence of hypertensive end-stage renal disease? Arch Intern Med.1991;151:1359-1364.
Not Available. Statistics Bureau and Statistics Center: Annual Report on Current
Population Estimates [as of October 1, 1998]. Tokyo: Management and Coordination Agency of Japan; 1998.
Ministry of Health and Welfare. Map of National Health Insurance Health Care Costs. Tokyo, Japan: Ministry of Health and Welfare; 1995.
Not Available. Japanese Society of Nephrology Membership Directory . Tokyo: Japanese Society of Nephrology; 1997.
Not Available. Institutional Membership Directory, Japanese Society for Dialysis
Therapy . Tokyo: Japanese Society for Dialysis Therapy; 1997.
Sasaki N. High blood pressure and the salt intake of the Japanese. Jpn Heart J.1962;3:312-324.
Kawamura M, Kimura Y, Takahashi K.
et al. Relation of urinary sodium excretion to blood pressure, glucose metabolism,
and lipid metabolism in residents of an area of Japan with high sodium intake. Hypertens Res.1997;20:287-293.
Dahl LK. Possible role of chronic excess salt consumption in the pathogenesis
of essential hypertension. Am J Cardiol.1961;8:571-575.
Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr.1997;65(suppl 2):626S-642S.
Tanaka H, Tanaka Y, Hayashi M.
et al. Secular trends in mortality for cerebrovascular diseases in Japan,
1960 to 1979. Stroke.1982;13:574-581.
Omura T, Hisamatsu S, Takizawa Y, Minowa M, Yanagawa H, Shigematsu I. Geographical distribution of cerebrovascular disease mortality and
food intakes in Japan. Soc Sci Med.1987;24:401-407.
Joossens JV, Geboers J. Salt and hypertension. Prev Med.1983;12:53-59.
MacGregor GA. Salt: more adverse effects [review]. Am J Hypertens.1997;10:37S-41S.
Zatz R, Dunn BR, Meyer TW, Anderson S, Renneke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration
of glomerular capillary hypertenstion. J Clin Invest.1986;77:1925-1930.
Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting
progressive renal disease associated with systemic hypertension in the rat. J Clin Invest.1986;77:1993-2000.
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.for the Collaborative Study Group. The Effect of angiotensin-converting-enzyme inhibition on diabetic
nephropathy. N Engl J Med.1993;329:1456-1462.